| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |